1887

Abstract

Murine norovirus (MNV) is widely used as a model for studying norovirus biology. While MNV isolates vary in their pathogenesis, infection of immunocompetent mice mostly results in persistent infection. The ability of a virus to establish a persistent infection is dependent on its ability to subvert or avoid the host immune response. Previously, we described the identification and characterization of virulence factor 1 (VF1) in MNV, and demonstrated its role as an innate immune antagonist. Here, we explore the role of VF1 during persistent MNV infection in an immunocompetent host. Using reverse genetics, we generated MNV-3 viruses carrying a single or a triple termination codon inserted in the VF1 ORF. VF1-deleted MNV-3 replicated to comparable levels to the wildtype virus in tissue culture. Comparative studies between MNV-3 and an acute MNV-1 strain show that MNV-3 VF1 exerts the same functions as MNV-1 VF1, but with reduced potency. C57BL/6 mice infected with VF1-deleted MNV-3 showed significantly reduced replication kinetics during the acute phase of the infection, but viral loads rapidly reached the levels seen in mice infected with wildtype virus after phenotypic restoration of VF1 expression. Infection with an MNV-3 mutant that had three termination codons inserted into VF1, in which reversion was suppressed, resulted in consistently lower replication throughout a 3 month persistent infection in mice, suggesting a role for VF1 in viral fitness . Our results indicate that VF1 expressed by a persistent strain of MNV also functions to antagonize the innate response to infection. We found that VF1 is not essential for viral persistence, but instead contributes to viral fitness in mice. These data fit with the hypothesis that noroviruses utilize multiple mechanisms to avoid and/or control the host response to infection and that VF1 is just one component of this.

Funding
This study was supported by the:
  • biotechnology and biological sciences research council (Award BB/K002465/1)
    • Principle Award Recipient: FrédéricSorgeloos
  • wellcome trust (Award 207498/Z/17/Z)
    • Principle Award Recipient: IanG. Goodfellow
  • presidential special scholarship scheme for innovation and development (nigeria)
    • Principle Award Recipient: AminuS. Jahun
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.001651
2021-09-07
2022-09-30
Loading full text...

Full text loading...

/deliver/fulltext/jgv/102/9/jgv001651.html?itemId=/content/journal/jgv/10.1099/jgv.0.001651&mimeType=html&fmt=ahah

References

  1. Lopman BA, Steele D, Kirkwood CD, Parashar UD. The vast and varied global burden of norovirus: prospects for prevention and control. PLOS Med 2016; 13:e1001999 [View Article] [PubMed]
    [Google Scholar]
  2. Bányai K, Estes MK, Martella V, Parashar UD. Viral gastroenteritis. Lancet 2018; 392:175–186 [View Article] [PubMed]
    [Google Scholar]
  3. Patel MM, Hall AJ, Vinjé J, Parashar UD. Noroviruses: A comprehensive review. J Clin Virol 2009; 44:1–8 [View Article] [PubMed]
    [Google Scholar]
  4. Ramani S, Kang G. Viruses causing childhood diarrhoea in the developing world. Curr Opin Infect Dis 2009; 22:477–482 [View Article] [PubMed]
    [Google Scholar]
  5. Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW. STAT1-dependent innate immunity to a Norwalk-Like Virus. Science 299:1575–1578 [View Article] [PubMed]
    [Google Scholar]
  6. Karst SM, Wobus CE, Goodfellow IG, Green KY, Virgin HW. Advances in norovirus biology. Cell Host Microbe 2014; 15:668–680 [View Article] [PubMed]
    [Google Scholar]
  7. Baldridge MT, Turula H, Wobus CE. Norovirus regulation by host and microbe. Trends Mol Med 2016; 22:1047–1059 [View Article] [PubMed]
    [Google Scholar]
  8. Hsu CC, Riley LK, Wills HM, Livingston RS. Persistent infection with and serologic cross-reactivity of three novel murine noroviruses. Comp Med 2006; 56:247–251 [PubMed]
    [Google Scholar]
  9. Smith DB, McFadden N, Blundell RJ, Meredith A, Simmonds P. Diversity of murine norovirus in wild-rodent populations: species-specific associations suggest an ancient divergence. J Gen Virol 2012; 93:259–266 [View Article] [PubMed]
    [Google Scholar]
  10. Chaudhry Y, Skinner MA, Goodfellow IG. Recovery of genetically defined murine norovirus in tissue culture by using a fowlpox virus expressing T7 RNA polymerase. J Gen Virol 2007; 88:2091–2100 [View Article] [PubMed]
    [Google Scholar]
  11. Arias A, Bailey D, Chaudhry Y, Goodfellow I. Development of a reverse-genetics system for murine norovirus 3: long-term persistence occurs in the caecum and colon. J Gen Virol 2012; 93:1432–1441 [View Article] [PubMed]
    [Google Scholar]
  12. Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev S et al. Replication of Norovirus in cell culture reveals a tropism for dendritic cells and macrophages. Michael Emerman, editor. PLoS Biol 2004; 2:e432 [View Article] [PubMed]
    [Google Scholar]
  13. Barron EL, Sosnovtsev S, Bok K, Prikhodko V, Sandoval-Jaime C et al. Diversity of murine norovirus strains isolated from asymptomatic mice of different genetic backgrounds within a single U.S. research institute. PLoS One 2011; 6:e21435 [View Article] [PubMed]
    [Google Scholar]
  14. Kahan SM, Liu G, Reinhard MK, Hsu CC, Livingston RS et al. Comparative murine norovirus studies reveal a lack of correlation between intestinal virus titers and enteric pathology. Virology 2011; 421:202–210 [View Article] [PubMed]
    [Google Scholar]
  15. McFadden N, Arias A, Dry I, Bailey D, Witteveldt J et al. Influence of genome-scale RNA structure disruption on the replication of murine norovirus--similar replication kinetics in cell culture but attenuation of viral fitness in vivo. Nucleic Acids Res 20131–16
    [Google Scholar]
  16. Nice TJ, Robinson BA, Van Winkle JA. The Role of interferon in persistent viral infection: insights from murine norovirus. Trends Microbiol 2018; 26:510–524 [View Article] [PubMed]
    [Google Scholar]
  17. Thorne LG, Goodfellow IG. Norovirus gene expression and replication. J Gen Virol 2013; 44:
    [Google Scholar]
  18. Thackray LB, Wobus CE, Chachu KA, Liu B, Alegre ER et al. Murine noroviruses comprising a single genogroup exhibit biological diversity despite limited sequence divergence. J Virol 2007; 81:10460–10473 [View Article] [PubMed]
    [Google Scholar]
  19. McFadden N, Bailey D, Carrara G, Benson A, Chaudhry Y et al. Norovirus regulation of the innate immune response and apoptosis occurs via the product of the alternative open reading frame 4. Basler CF, editor. PLoS Pathog 2011; 7:e1002413 [View Article] [PubMed]
    [Google Scholar]
  20. Oka T, Wang Q, Katayama K, Saif LJ. Comprehensive review of human sapoviruses. Clin Microbiol Rev 2015; 28:32–53 [View Article] [PubMed]
    [Google Scholar]
  21. Sullivan BM, Teijaro JR, de la Torre JC, Oldstone MB. Early virus-host interactions dictate the course of a persistent infection. PLoS Pathog 2015; 11:e1004588 [View Article] [PubMed]
    [Google Scholar]
  22. Morikawa K, Lange CM, Gouttenoire J, Meylan E, Brass V et al. Nonstructural protein 3-4A: the Swiss army knife of hepatitis C virus. J Viral Hepat 2011; 18:305–315 [View Article] [PubMed]
    [Google Scholar]
  23. Thorne L, Lu J, Chaudhry Y, Goodfellow I. miR-155 induction is a marker of murine norovirus infection but does not contribute to control of replication in vivo. Wellcome open Res 2018; 3:42 [View Article] [PubMed]
    [Google Scholar]
  24. Emmott E, Sweeney TR, Goodfellow I. A Cell-based Fluorescence Resonance Energy Transfer (FRET) sensor reveals inter- and intragenogroup variations in norovirus protease activity and polyprotein cleavage. J Biol Chem 2015; 290:27841–27853 [View Article] [PubMed]
    [Google Scholar]
  25. Animals (Scientific Procedures) Act 1986 Statute law database; 1986 https://www.legislation.gov.uk/ukpga/1986/14/contents
  26. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 298:e1000412
    [Google Scholar]
  27. Roberts ZJ, Goutagny N, Perera P-Y, Kato H, Kumar H et al. The chemotherapeutic agent DMXAA potently and specifically activates the TBK1-IRF-3 signaling axis. J Exp Med 2007; 204:1559–1569 [View Article] [PubMed]
    [Google Scholar]
  28. Chojnacki S, Cowley A, Lee J, Foix A, Lopez R. Programmatic access to bioinformatics tools from EMBL-EBI update: 2017. Nucleic Acids Res 2017; 45:W550–3 [View Article] [PubMed]
    [Google Scholar]
  29. Zhu S, Regev D, Watanabe M, Hickman D, Moussatche N et al. Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains. Heise MT, editor. PLoS Pathog 2013; 9:e1003592 [View Article] [PubMed]
    [Google Scholar]
  30. Zamarin D, Ortigoza MB, Palese P. Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. J Virol 2006; 80:7976–7983 [View Article] [PubMed]
    [Google Scholar]
  31. Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM et al. Interferon-λ cures persistent murine norovirus infection in the absence of adaptive immunity. Science 2015; 347:269–273 [View Article] [PubMed]
    [Google Scholar]
  32. Baldridge MT, Lee S, Brown JJ, McAllister N, Urbanek K et al. Expression of Ifnlr1 on intestinal epithelial cells is critical to the antiviral effects of interferon lambda against norovirus and reovirus. López S, editor. J Virol 2017; 91: [View Article] [PubMed]
    [Google Scholar]
  33. Lee S, Wilen CB, Orvedahl A, McCune BT, Kim KW et al. Norovirus cell tropism is determined by combinatorial action of a viral non-structural protein and host cytokine. Cell Host Microbe 2017; 22:449–459 [View Article] [PubMed]
    [Google Scholar]
  34. Nice TJ, Osborne LC, Tomov VT, Artis D, Wherry EJ et al. Type I interferon receptor deficiency in dendritic cells facilitates systemic murine norovirus persistence despite enhanced adaptive immunity. Coyne CB, editor. PLOS Pathog 2016; 12:e1005684 [View Article] [PubMed]
    [Google Scholar]
  35. Bowie AG, Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008; 8:911–922 [View Article] [PubMed]
    [Google Scholar]
  36. Schröder M, Bowie AG. An arms race: innate antiviral responses and counteracting viral strategies. Biochem Soc Trans 2007; 35:1512–1514 [View Article] [PubMed]
    [Google Scholar]
  37. Hsu CC, Riley LK, Livingston RS. Molecular characterization of three novel murine noroviruses. Virus Genes 2007; 34:147–155 [View Article] [PubMed]
    [Google Scholar]
  38. Arias A, Thorne L, Goodfellow I. Favipiravir elicits antiviral mutagenesis during virus replication in vivo. elife 2014; 3:e03679 [View Article] [PubMed]
    [Google Scholar]
  39. Niendorf S, Klemm U, Mas Marques A, Bock C-T, Höhne M. Infection with the persistent murine norovirus strain MNV-S99 suppresses IFN-beta release and activation of stat1 in vitro. PLoS One 2016; 11:e0156898 [View Article] [PubMed]
    [Google Scholar]
  40. MacDuff DA, Baldridge MT, Qaqish AM, Nice TJ, Darbandi AD et al. HOIL1 is essential for the induction of type I and III interferons by MDA5 and regulates persistent murine norovirus infection. Pfeiffer JK, editor. J Virol 2018; 92: [View Article] [PubMed]
    [Google Scholar]
  41. Wilen CB, Lee S, Hsieh LL, Orchard RC, Desai C et al. Tropism for tuft cells determines immune promotion of norovirus pathogenesis. Science 2018; 360:204–208 [View Article] [PubMed]
    [Google Scholar]
  42. Mahlakõiv T, Hernandez P, Gronke K, Diefenbach A, Staeheli P. Leukocyte-derived IFN-α/β and epithelial IFN-λ constitute a compartmentalized mucosal defense system that restricts enteric virus infections. Greenberg HB, editor. PLoS Pathog 2015; 11:e1004782 [View Article] [PubMed]
    [Google Scholar]
  43. Lee S, Liu H, Wilen CB, Sychev ZE, Desai C et al. A secreted viral nonstructural protein determines intestinal norovirus pathogenesis. Cell Host Microbe 2019; 0:
    [Google Scholar]
  44. Nice TJ, Strong DW, McCune BT, Pohl CS, Virgin HW. A single-amino-acid change in murine norovirus ns1/2 is sufficient for colonic tropism and persistence. J Virol 2013; 87:327–334 [View Article] [PubMed]
    [Google Scholar]
  45. Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A et al. Commensal microbes and interferon- determine persistence of enteric murine norovirus infection. Science 2015; 347:266–269 [View Article] [PubMed]
    [Google Scholar]
  46. Sullender ME, Baldridge MT. Norovirus interactions with the commensal microbiota. Condit RC, editor. PLOS Pathog 2018; 14:e1007183 [View Article] [PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.001651
Loading
/content/journal/jgv/10.1099/jgv.0.001651
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error